Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Bone Morphogenetic Protein (BMP) Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Bone Morphogenetic Protein (BMP) Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-09-11
Pages: 119 Pages
Report ld: 5045354
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Bone Morphogenetic Protein (BMP) Market Size(US$)
CAGR 2025-2031
9.1%
Market Size,2031
USD 1,284
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 760 million
Market Forecast in 2031(Value)
US$ 1,284 million
CAGR
9.1%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Bone Morphogenetic Protein (BMP) market is projected to grow from US$ 703 million in 2024 to US$ 1284 million by 2031, at a CAGR of 9.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance.
Human recombinant BMP7 has surgical uses and was originally marketed under the brand name OP1 (Olympus Biotech, who bought it from Stryker). It can be used to aid in the fusion of vertebral bodies to prevent neurologic trauma. rhBMP-7 has withdrawn off the market. rhBMP-4 and rhBMP-6 do not have commercial product launched. Therefore, in this report, we only study the rhBMP-2.
Bone Morphogenetic Protein 2 (BMP-2) is a member of the bone morphogenetic protein family, a group of proteins that play a crucial role in bone and cartilage formation during embryonic development and adult tissue repair. BMP-2 is known for its potent osteoinductive properties, meaning it has the ability to stimulate the differentiation of mesenchymal stem cells into osteoblasts, the cells responsible for bone formation. This property makes BMP-2 a valuable therapeutic agent in orthopedic and dental surgeries, particularly in procedures aimed at promoting bone regeneration and spinal fusion.
The global core manufacturers of Bone Morphogenetic Protein (BMP) include Medtronic, Jiuyuan Gene Engineering and Cellumed. The top three companies have a market share of about 99%. North America is the largest global market for Bone Morphogenetic Protein (BMP) with a market share of approximately 69%, followed by Asia Pacific and Europe with a market share of 19% and 9%, respectively. In terms of application, Spinal Fusion is the largest downstream segment, accounting for approximately 73% of the market.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Bone Morphogenetic Protein (BMP) market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Medtronic
- Jiuyuan Gene Engineering
- Cellumed
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Sponge Carrier
- Hydroxyapatite Carrier
Segment by Application
- Spinal Fusion
- Trauma Surgery
- Oral Maxillofacial Surgery
- Reconstructive
CHAPTER OUTLINE
Chapter 1: Defines the Bone Morphogenetic Protein (BMP) study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Bone Morphogenetic Protein (BMP): Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Bone Morphogenetic Protein (BMP) Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Sponge Carrier
1.2.3 Hydroxyapatite Carrier
1.3 Market Segmentation by Application
1.3.1 Global Bone Morphogenetic Protein (BMP) Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Spinal Fusion
1.3.3 Trauma Surgery
1.3.4 Oral Maxillofacial Surgery
1.3.5 Reconstructive
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Bone Morphogenetic Protein (BMP) Revenue Estimates and Forecasts 2020-2031
2.2 Global Bone Morphogenetic Protein (BMP) Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Bone Morphogenetic Protein (BMP) Sales Estimates and Forecasts 2020-2031
2.4 Global Bone Morphogenetic Protein (BMP) Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Bone Morphogenetic Protein (BMP) Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Bone Morphogenetic Protein (BMP) Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Sponge Carrier Market Size by Manufacturers
3.5.2 Hydroxyapatite Carrier Market Size by Manufacturers
3.6 Global Bone Morphogenetic Protein (BMP) Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Bone Morphogenetic Protein (BMP) Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Bone Morphogenetic Protein (BMP) Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Bone Morphogenetic Protein (BMP) Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Bone Morphogenetic Protein (BMP) Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Bone Morphogenetic Protein (BMP) Sales and Revenue by Type (2020-2031)
6.4 North America Bone Morphogenetic Protein (BMP) Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Bone Morphogenetic Protein (BMP) Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Bone Morphogenetic Protein (BMP) Sales and Revenue by Type (2020-2031)
7.4 Europe Bone Morphogenetic Protein (BMP) Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Bone Morphogenetic Protein (BMP) Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Bone Morphogenetic Protein (BMP) Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Bone Morphogenetic Protein (BMP) Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Bone Morphogenetic Protein (BMP) Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Bone Morphogenetic Protein (BMP) Sales and Revenue by Type (2020-2031)
9.4 Central and South America Bone Morphogenetic Protein (BMP) Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Bone Morphogenetic Protein (BMP) Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Bone Morphogenetic Protein (BMP) Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Bone Morphogenetic Protein (BMP) Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Bone Morphogenetic Protein (BMP) Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Bone Morphogenetic Protein (BMP) Product Models, Descriptions and Specifications
11.1.4 Medtronic Bone Morphogenetic Protein (BMP) Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Medtronic Bone Morphogenetic Protein (BMP) Sales by Product in 2024
11.1.6 Medtronic Bone Morphogenetic Protein (BMP) Sales by Application in 2024
11.1.7 Medtronic Bone Morphogenetic Protein (BMP) Sales by Geographic Area in 2024
11.1.8 Medtronic Bone Morphogenetic Protein (BMP) SWOT Analysis
11.1.9 Medtronic Recent Developments
11.2 Jiuyuan Gene Engineering
11.2.1 Jiuyuan Gene Engineering Corporation Information
11.2.2 Jiuyuan Gene Engineering Business Overview
11.2.3 Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) Product Models, Descriptions and Specifications
11.2.4 Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) Sales by Product in 2024
11.2.6 Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) Sales by Application in 2024
11.2.7 Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) Sales by Geographic Area in 2024
11.2.8 Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) SWOT Analysis
11.2.9 Jiuyuan Gene Engineering Recent Developments
11.3 Cellumed
11.3.1 Cellumed Corporation Information
11.3.2 Cellumed Business Overview
11.3.3 Cellumed Bone Morphogenetic Protein (BMP) Product Models, Descriptions and Specifications
11.3.4 Cellumed Bone Morphogenetic Protein (BMP) Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Cellumed Bone Morphogenetic Protein (BMP) Sales by Product in 2024
11.3.6 Cellumed Bone Morphogenetic Protein (BMP) Sales by Application in 2024
11.3.7 Cellumed Bone Morphogenetic Protein (BMP) Sales by Geographic Area in 2024
11.3.8 Cellumed Bone Morphogenetic Protein (BMP) SWOT Analysis
11.3.9 Cellumed Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Bone Morphogenetic Protein (BMP) Industry Chain
12.2 Bone Morphogenetic Protein (BMP) Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Bone Morphogenetic Protein (BMP) Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Bone Morphogenetic Protein (BMP) Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Bone Morphogenetic Protein (BMP) Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Bone Morphogenetic Protein (BMP) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Bone Morphogenetic Protein (BMP) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Bone Morphogenetic Protein (BMP) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Bone Morphogenetic Protein (BMP) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Bone Morphogenetic Protein (BMP) Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Bone Morphogenetic Protein (BMP) Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Bone Morphogenetic Protein (BMP) Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Bone Morphogenetic Protein (BMP) Sales by Region (2020-2025) & (K Units)
Table 8. Global Bone Morphogenetic Protein (BMP) Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Bone Morphogenetic Protein (BMP) Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Bone Morphogenetic Protein (BMP) Sales Share by Manufacturers (2020-2025)
Table 12. Global Bone Morphogenetic Protein (BMP) Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Bone Morphogenetic Protein (BMP) Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Bone Morphogenetic Protein (BMP) by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bone Morphogenetic Protein (BMP) as of 2024)
Table 16. Global Bone Morphogenetic Protein (BMP) Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Bone Morphogenetic Protein (BMP) Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Bone Morphogenetic Protein (BMP) Manufacturing Base and Headquarters
Table 19. Global Bone Morphogenetic Protein (BMP) Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Bone Morphogenetic Protein (BMP) Sales by Type (2020-2025) & (K Units)
Table 23. Global Bone Morphogenetic Protein (BMP) Sales by Type (2026-2031) & (K Units)
Table 24. Global Bone Morphogenetic Protein (BMP) Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Bone Morphogenetic Protein (BMP) Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Bone Morphogenetic Protein (BMP) ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Bone Morphogenetic Protein (BMP) Sales by Application (2020-2025) & (K Units)
Table 29. Global Bone Morphogenetic Protein (BMP) Sales by Application (2026-2031) & (K Units)
Table 30. Bone Morphogenetic Protein (BMP) High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Bone Morphogenetic Protein (BMP) Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Bone Morphogenetic Protein (BMP) Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Bone Morphogenetic Protein (BMP) ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Bone Morphogenetic Protein (BMP) Growth Accelerators and Market Barriers
Table 37. North America Bone Morphogenetic Protein (BMP) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Bone Morphogenetic Protein (BMP) Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Bone Morphogenetic Protein (BMP) Growth Accelerators and Market Barriers
Table 40. Europe Bone Morphogenetic Protein (BMP) Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Bone Morphogenetic Protein (BMP) Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Bone Morphogenetic Protein (BMP) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Bone Morphogenetic Protein (BMP) Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Bone Morphogenetic Protein (BMP) Growth Accelerators and Market Barriers
Table 45. Southeast Asia Bone Morphogenetic Protein (BMP) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Bone Morphogenetic Protein (BMP) Investment Opportunities and Key Challenges
Table 47. Central and South America Bone Morphogenetic Protein (BMP) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Bone Morphogenetic Protein (BMP) Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Bone Morphogenetic Protein (BMP) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Medtronic Corporation Information
Table 51. Medtronic Description and Major Businesses
Table 52. Medtronic Product Models, Descriptions and Specifications
Table 53. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Medtronic Sales Value Proportion by Product in 2024
Table 55. Medtronic Sales Value Proportion by Application in 2024
Table 56. Medtronic Sales Value Proportion by Geographic Area in 2024
Table 57. Medtronic Bone Morphogenetic Protein (BMP) SWOT Analysis
Table 58. Medtronic Recent Developments
Table 59. Jiuyuan Gene Engineering Corporation Information
Table 60. Jiuyuan Gene Engineering Description and Major Businesses
Table 61. Jiuyuan Gene Engineering Product Models, Descriptions and Specifications
Table 62. Jiuyuan Gene Engineering Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Jiuyuan Gene Engineering Sales Value Proportion by Product in 2024
Table 64. Jiuyuan Gene Engineering Sales Value Proportion by Application in 2024
Table 65. Jiuyuan Gene Engineering Sales Value Proportion by Geographic Area in 2024
Table 66. Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) SWOT Analysis
Table 67. Jiuyuan Gene Engineering Recent Developments
Table 68. Cellumed Corporation Information
Table 69. Cellumed Description and Major Businesses
Table 70. Cellumed Product Models, Descriptions and Specifications
Table 71. Cellumed Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Cellumed Sales Value Proportion by Product in 2024
Table 73. Cellumed Sales Value Proportion by Application in 2024
Table 74. Cellumed Sales Value Proportion by Geographic Area in 2024
Table 75. Cellumed Bone Morphogenetic Protein (BMP) SWOT Analysis
Table 76. Cellumed Recent Developments
Table 77. Key Raw Materials Distribution
Table 78. Raw Materials Key Suppliers
Table 79. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 80. Milestones in Production Technology Evolution
Table 81. Distributors List
Table 82. Market Trends and Market Evolution
Table 83. Market Drivers and Opportunities
Table 84. Market Challenges, Risks, and Restraints
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
List of Figures
Figure 1. Bone Morphogenetic Protein (BMP) Product Picture
Figure 2. Global Bone Morphogenetic Protein (BMP) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Sponge Carrier Product Picture
Figure 4. Hydroxyapatite Carrier Product Picture
Figure 5. Global Bone Morphogenetic Protein (BMP) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Spinal Fusion
Figure 7. Trauma Surgery
Figure 8. Oral Maxillofacial Surgery
Figure 9. Reconstructive
Figure 10. Bone Morphogenetic Protein (BMP) Report Years Considered
Figure 11. Global Bone Morphogenetic Protein (BMP) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Bone Morphogenetic Protein (BMP) Revenue (2020-2031) & (US$ Million)
Figure 13. Global Bone Morphogenetic Protein (BMP) Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Bone Morphogenetic Protein (BMP) Revenue Market Share by Region (2020-2031)
Figure 15. Global Bone Morphogenetic Protein (BMP) Sales (2020-2031) & (K Units)
Figure 16. Global Bone Morphogenetic Protein (BMP) Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Bone Morphogenetic Protein (BMP) Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Bone Morphogenetic Protein (BMP) Sales Volume Market Share in 2024
Figure 19. Global Bone Morphogenetic Protein (BMP) Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Sponge Carrier Revenue Market Share by Manufacturer in 2024
Figure 22. Hydroxyapatite Carrier Revenue Market Share by Manufacturer in 2024
Figure 23. Global Bone Morphogenetic Protein (BMP) Sales Market Share by Type (2020-2031)
Figure 24. Global Bone Morphogenetic Protein (BMP) Revenue Market Share by Type (2020-2031)
Figure 25. Global Bone Morphogenetic Protein (BMP) Sales Market Share by Application (2020-2031)
Figure 26. Global Bone Morphogenetic Protein (BMP) Revenue Market Share by Application (2020-2031)
Figure 27. North America Bone Morphogenetic Protein (BMP) Sales YoY (2020-2031) & (K Units)
Figure 28. North America Bone Morphogenetic Protein (BMP) Revenue YoY (2020-2031) & (US$ Million)
Figure 29. North America Top 5 Manufacturers Bone Morphogenetic Protein (BMP) Sales Revenue (US$ Million) in 2024
Figure 30. North America Bone Morphogenetic Protein (BMP) Sales Volume (K Units) by Type (2020- 2031)
Figure 31. North America Bone Morphogenetic Protein (BMP) Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 32. North America Bone Morphogenetic Protein (BMP) Sales Volume (K Units) by Application (2020-2031)
Figure 33. North America Bone Morphogenetic Protein (BMP) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 34. US Bone Morphogenetic Protein (BMP) Revenue (2020-2031) & (US$ Million)
Figure 35. Canada Bone Morphogenetic Protein (BMP) Revenue (2020-2031) & (US$ Million)
Figure 36. Mexico Bone Morphogenetic Protein (BMP) Revenue (2020-2031) & (US$ Million)
Figure 37. Europe Bone Morphogenetic Protein (BMP) Sales YoY (2020-2031) & (K Units)
Figure 38. Europe Bone Morphogenetic Protein (BMP) Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Europe Top 5 Manufacturers Bone Morphogenetic Protein (BMP) Sales Revenue (US$ Million) in 2024
Figure 40. Europe Bone Morphogenetic Protein (BMP) Sales Volume (K Units) by Type (2020-2031)
Figure 41. Europe Bone Morphogenetic Protein (BMP) Sales Revenue (US$ Million) by Type (2020-2031)
Figure 42. Europe Bone Morphogenetic Protein (BMP) Sales Volume (K Units) by Application (2020-2031)
Figure 43. Europe Bone Morphogenetic Protein (BMP) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. Germany Bone Morphogenetic Protein (BMP) Revenue (2020-2031) & (US$ Million)
Figure 45. France Bone Morphogenetic Protein (BMP) Revenue (2020-2031) & (US$ Million)
Figure 46. U.K. Bone Morphogenetic Protein (BMP) Revenue (2020-2031) & (US$ Million)
Figure 47. Italy Bone Morphogenetic Protein (BMP) Revenue (2020-2031) & (US$ Million)
Figure 48. Russia Bone Morphogenetic Protein (BMP) Revenue (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Bone Morphogenetic Protein (BMP) Sales YoY (2020-2031) & (K Units)
Figure 50. Asia-Pacific Bone Morphogenetic Protein (BMP) Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Top 8 Manufacturers Bone Morphogenetic Protein (BMP) Sales Revenue (US$ Million) in 2024
Figure 52. Asia-Pacific Bone Morphogenetic Protein (BMP) Sales Volume (K Units) by Type (2020- 2031)
Figure 53. Asia-Pacific Bone Morphogenetic Protein (BMP) Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 54. Asia-Pacific Bone Morphogenetic Protein (BMP) Sales Volume (K Units) by Application (2020-2031)
Figure 55. Asia-Pacific Bone Morphogenetic Protein (BMP) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 56. Indonesia Bone Morphogenetic Protein (BMP) Revenue (2020-2031) & (US$ Million)
Figure 57. Japan Bone Morphogenetic Protein (BMP) Revenue (2020-2031) & (US$ Million)
Figure 58. South Korea Bone Morphogenetic Protein (BMP) Revenue (2020-2031) & (US$ Million)
Figure 59. China Taiwan Bone Morphogenetic Protein (BMP) Revenue (2020-2031) & (US$ Million)
Figure 60. India Bone Morphogenetic Protein (BMP) Revenue (2020-2031) & (US$ Million)
Figure 61. Central and South America Bone Morphogenetic Protein (BMP) Sales YoY (2020-2031) & (K Units)
Figure 62. Central and South America Bone Morphogenetic Protein (BMP) Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Central and South America Top 5 Manufacturers Bone Morphogenetic Protein (BMP) Sales Revenue (US$ Million) in 2024
Figure 64. Central and South America Bone Morphogenetic Protein (BMP) Sales Volume (K Units) by Type (2021-2031)
Figure 65. Central and South America Bone Morphogenetic Protein (BMP) Sales Revenue (US$ Million) by Type (2020-2031)
Figure 66. Central and South America Bone Morphogenetic Protein (BMP) Sales Volume (K Units) by Application (2020-2031)
Figure 67. Central and South America Bone Morphogenetic Protein (BMP) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 68. Brazil Bone Morphogenetic Protein (BMP) Revenue (2020-2025) & (US$ Million)
Figure 69. Argentina Bone Morphogenetic Protein (BMP) Revenue (2020-2025) & (US$ Million)
Figure 70. Middle East, and Africa Bone Morphogenetic Protein (BMP) Sales YoY (2020-2031) & (K Units)
Figure 71. Middle East and Africa Bone Morphogenetic Protein (BMP) Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Middle East and Africa Top 5 Manufacturers Bone Morphogenetic Protein (BMP) Sales Revenue (US$ Million) in 2024
Figure 73. Middle East and Africa Bone Morphogenetic Protein (BMP) Sales Volume (K Units) by Type (2021-2031)
Figure 74. South America Bone Morphogenetic Protein (BMP) Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Middle East and Africa Bone Morphogenetic Protein (BMP) Sales Volume (K Units) by Application (2020-2031)
Figure 76. Middle East and Africa Bone Morphogenetic Protein (BMP) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. GCC Countries Bone Morphogenetic Protein (BMP) Revenue (2020-2025) & (US$ Million)
Figure 78. Turkey Bone Morphogenetic Protein (BMP) Revenue (2020-2025) & (US$ Million)
Figure 79. Egypt Bone Morphogenetic Protein (BMP) Revenue (2020-2025) & (US$ Million)
Figure 80. South Africa Bone Morphogenetic Protein (BMP) Revenue (2020-2025) & (US$ Million)
Figure 81. Bone Morphogenetic Protein (BMP) Industry Chain Mapping
Figure 82. Regional Bone Morphogenetic Protein (BMP) Manufacturing Base Distribution (%)
Figure 83. Global Bone Morphogenetic Protein (BMP) Production Market Share by Region (2020-2031)
Figure 84. Bone Morphogenetic Protein (BMP) Production Process
Figure 85. Regional Bone Morphogenetic Protein (BMP) Production Cost Structure
Figure 86. Channels of Distribution (Direct Vs Distribution)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Bone Morphogenetic Protein (BMP) in 2025?
The global market size of Bone Morphogenetic Protein (BMP) in 2025 was 760 Million USD.
What is the annual compound growth rate of the global Bone Morphogenetic Protein (BMP) market size from 2025 to 2031?
Which companies rank high in the global Bone Morphogenetic Protein (BMP) market?
Which region is expected to have the highest market share?
What was the global market size of Bone Morphogenetic Protein (BMP) in 2031?
Related Reports
Global Bone Morphogenetic Protein (BMP) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Bone Morphogenetic Protein (BMP) market size was US$ 760 million in 2025 and is forecast to reach a readjusted size of US$ 1389 million by 2032 with a CAGR of 9.1% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 74
USD 4250.00
(Single User License)
Global Bone Morphogenetic Protein (BMP) Market Research Report 2026
The global Bone Morphogenetic Protein (BMP) market was valued at US$ 760 million in 2025 and is anticipated to reach US$ 1389 million by 2032, at a CAGR of 9.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 102
USD 2900.00
(Single User License)
Bone Morphogenetic Protein (BMP)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Bone Morphogenetic Protein (BMP) was estimated to be worth US$ 760 million in 2025 and is projected to reach US$ 1389 million, growing at a CAGR of 9.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 87
USD 3950.00
(Single User License)
Global Bone Morphogenetic Protein (BMP) Market Research Report 2025
The global market for Bone Morphogenetic Protein (BMP) was valued at US$ 703 million in the year 2024 and is projected to reach a revised size of US$ 1284 million by 2031, growing at a CAGR of 9.1% during the forecast period.
Published Date: 2025-05-12
Pages: 75
USD 2900.00
(Single User License)
Bone Morphogenetic Protein (BMP) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Bone Morphogenetic Protein (BMP) was estimated to be worth US$ 703 million in 2024 and is forecast to a readjusted size of US$ 1284 million by 2031 with a CAGR of 9.1% during the forecast period 2025-2031.
Published Date: 2025-05-10
Pages: 84
USD 3950.00
(Single User License)
Global Bone Morphogenetic Protein (BMP) Market Insights, Forecast to 2031
The global Bone Morphogenetic Protein (BMP) market is projected to grow from US$ 760 million in 2025 to US$ 1284 million by 2031, at a Compound Annual Growth Rate (CAGR) of 9.1% during the forecast period.
Published Date: 2025-05-10
Pages: 116
USD 4900.00
(Single User License)
Global Bone Morphogenetic Protein (BMP) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Bone Morphogenetic Protein (BMP) market size was US$ 703 million in 2024 and is forecast to a readjusted size of US$ 1284 million by 2031 with a CAGR of 9.1% during the forecast period 2025-2031.
Published Date: 2025-05-10
Pages: 71
USD 4250.00
(Single User License)
Global Bone Morphogenetic Protein (BMP) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Bone Morphogenetic Protein (BMP) was estimated to be worth US$ 703 million and is forecast to reach approximately US$ 1284 million by 2031 with a CAGR of 9.1% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 108
USD 5900.00
(Single User License)
Bone Morphogenetic Protein (BMP)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Bone Morphogenetic Protein (BMP) was estimated to be worth US$ 703 million in 2024 and is forecast to a readjusted size of US$ 1284 million by 2031 with a CAGR of 9.1% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 87
USD 3950.00
(Single User License)
Global and United States Bone Morphogenetic Protein (BMP) Market Report & Forecast 2024-2030
Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance.
Published Date: 2024-05-27
Pages: 85
USD 4350.00
(Single User License)
Global Bone Morphogenetic Protein (BMP) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Bone Morphogenetic Protein (BMP) market size was US$ 760 million in 2025 and is forecast to reach a readjusted size of US$ 1389 million by 2032 with a CAGR of 9.1% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 74
USD 4250.00 (Single User License)Global Bone Morphogenetic Protein (BMP) Market Research Report 2026
The global Bone Morphogenetic Protein (BMP) market was valued at US$ 760 million in 2025 and is anticipated to reach US$ 1389 million by 2032, at a CAGR of 9.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 102
USD 2900.00 (Single User License)Bone Morphogenetic Protein (BMP)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Bone Morphogenetic Protein (BMP) was estimated to be worth US$ 760 million in 2025 and is projected to reach US$ 1389 million, growing at a CAGR of 9.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 87
USD 3950.00 (Single User License)Global Bone Morphogenetic Protein (BMP) Market Research Report 2025
The global market for Bone Morphogenetic Protein (BMP) was valued at US$ 703 million in the year 2024 and is projected to reach a revised size of US$ 1284 million by 2031, growing at a CAGR of 9.1% during the forecast period.
Published: 2025-05-12
Pages: 75
USD 2900.00 (Single User License)Bone Morphogenetic Protein (BMP) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Bone Morphogenetic Protein (BMP) was estimated to be worth US$ 703 million in 2024 and is forecast to a readjusted size of US$ 1284 million by 2031 with a CAGR of 9.1% during the forecast period 2025-2031.
Published: 2025-05-10
Pages: 84
USD 3950.00 (Single User License)Global Bone Morphogenetic Protein (BMP) Market Insights, Forecast to 2031
The global Bone Morphogenetic Protein (BMP) market is projected to grow from US$ 760 million in 2025 to US$ 1284 million by 2031, at a Compound Annual Growth Rate (CAGR) of 9.1% during the forecast period.
Published: 2025-05-10
Pages: 116
USD 4900.00 (Single User License)Global Bone Morphogenetic Protein (BMP) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Bone Morphogenetic Protein (BMP) market size was US$ 703 million in 2024 and is forecast to a readjusted size of US$ 1284 million by 2031 with a CAGR of 9.1% during the forecast period 2025-2031.
Published: 2025-05-10
Pages: 71
USD 4250.00 (Single User License)Global Bone Morphogenetic Protein (BMP) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Bone Morphogenetic Protein (BMP) was estimated to be worth US$ 703 million and is forecast to reach approximately US$ 1284 million by 2031 with a CAGR of 9.1% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 108
USD 5900.00 (Single User License)Bone Morphogenetic Protein (BMP)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Bone Morphogenetic Protein (BMP) was estimated to be worth US$ 703 million in 2024 and is forecast to a readjusted size of US$ 1284 million by 2031 with a CAGR of 9.1% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 87
USD 3950.00 (Single User License)Global and United States Bone Morphogenetic Protein (BMP) Market Report & Forecast 2024-2030
Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance.
Published: 2024-05-27
Pages: 85
USD 4350.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now